UnitedHealth Group (UNH) Stock Price, News & Analysis

Company Overview

UnitedHealth Group (NYSE: UNH), founded in 1977 and headquartered in Minnetonka, Minnesota, is a diversified healthcare company serving consumers, employers, physicians, hospitals and government entities. Through its two operating platforms, UnitedHealthcare and Optum, the company offers a broad array of health benefits and services designed to improve patient outcomes and optimize healthcare delivery. With a history spanning more than four decades, UnitedHealth Group has expanded its reach across the United States and selected international markets, leveraging data, technology and clinical insights to address evolving healthcare needs.

The UnitedHealthcare segment provides health insurance products and related services to individuals, employers and public sector programs. This includes fully insured and self-funded coverage options, Medicare and Medicaid plans, dental, vision, life and disability insurance, as well as health and wellness programs. UnitedHealthcare partners with an extensive network of care providers and employs digital tools and customer support initiatives to help members access care, manage chronic conditions and navigate complex healthcare systems.

The Optum segment applies data analytics, technology and clinical expertise to enhance healthcare delivery and pharmacy care. OptumHealth focuses on care delivery and management services, including primary care, urgent care and specialist networks. OptumInsight delivers software, advisory services and consulting to healthcare organizations, payers and life sciences companies. OptumRx provides pharmacy benefit management and specialty pharmacy services, supporting prescription drug benefit administration and medication adherence efforts.

Serving customers across all 50 states and in select global locations, UnitedHealth Group collaborates with providers, employers and governments to address quality, cost and access challenges in healthcare. Under the leadership of President and Chief Executive Officer Andrew Witty and a seasoned executive team, the company continues to invest in digital platforms, data-driven care models and strategic partnerships. Its commitment to innovation and integrated care positions UnitedHealth Group to meet the changing demands of the healthcare industry while striving to improve health outcomes and affordability.

AI Generated. May Contain Errors.

Key Stats

• Today's Range: $302.20 to $310.45
• 50-Day Range: $273.96 to $428.25
• 52-Week Range: $248.88 to $630.73
• Volume: 13.58 million shs
• Average Volume: 7.38 million shs
• Market Capitalization: $280.17 billion
• P/E Ratio: 12.93
• Dividend Yield: 2.86%
• Price Target: $415.57
• Consensus Rating: Moderate Buy

UnitedHealth Group Stock Analysis - MarketRank™

UnitedHealth Group scored higher than 100% of companies evaluated by MarketBeat, and ranked 3rd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

UnitedHealth Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 16 buy ratings, 8 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

UnitedHealth Group has been the subject of 23 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 12.46%

Earnings Growth

Earnings for UnitedHealth Group are expected to grow by 12.46% in the coming year, from $29.54 to $33.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of UnitedHealth Group is 12.93, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.09.

Price to Earnings Ratio vs. Sector

The P/E ratio of UnitedHealth Group is 12.93, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.25.

Price to Earnings Growth Ratio

UnitedHealth Group has a PEG Ratio of 1.46. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

UnitedHealth Group has a P/B Ratio of 2.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.30% of the float of UnitedHealth Group has been sold short.

Short Interest Ratio / Days to Cover

UnitedHealth Group has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in UnitedHealth Group has recently increased by 8.39%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

UnitedHealth Group pays a meaningful dividend of 2.86%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

UnitedHealth Group has been increasing its dividend for 15 years.

Dividend Coverage

The dividend payout ratio of UnitedHealth Group is 37.02%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, UnitedHealth Group will have a dividend payout ratio of 26.61% next year. This indicates that UnitedHealth Group will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -0.33

Percentage of Shares Shorted

1.30% of the float of UnitedHealth Group has been sold short.

Short Interest Ratio / Days to Cover

UnitedHealth Group has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in UnitedHealth Group has recently increased by 8.39%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.19

News Sentiment

UnitedHealth Group has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 102 news articles for UnitedHealth Group this week, compared to 68 articles on an average week.

Search Interest

Only 273 people have searched for UNH on MarketBeat in the last 30 days. This is a decrease of -56% compared to the previous 30 days.

MarketBeat Follows

Only 106 people have added UnitedHealth Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -42% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, UnitedHealth Group insiders have bought 17,494.57% more of their company's stock than they have sold. Specifically, they have bought $31,607,768.00 in company stock and sold $179,645.00 in company stock.

Percentage Held by Insiders

Only 0.28% of the stock of UnitedHealth Group is held by insiders.

Percentage Held by Institutions

87.86% of the stock of UnitedHealth Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

UNH Stock Analysis - Frequently Asked Questions

How have UNH shares performed this year?

UnitedHealth Group's stock was trading at $505.86 at the beginning of the year. Since then, UNH shares have decreased by 38.9% and is now trading at $308.8450.
View the best growth stocks for 2025 here.

How were UnitedHealth Group's earnings last quarter?

UnitedHealth Group Incorporated (NYSE:UNH) posted its earnings results on Thursday, April, 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by $0.09. The healthcare conglomerate had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a trailing twelve-month return on equity of 26.29% and a net margin of 5.39%.
Read the conference call transcript.

Does UnitedHealth Group have any subsidiaries?

UnitedHealth Group subsidiaries include LHC Group, PreferredOne, divvyDOSE, Diplomat Pharmacy, PatientsLikeMe, Equian, Avella Specialty Pharmacy, and others.

How do I buy shares of UnitedHealth Group?

Shares of UNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of UnitedHealth Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that UnitedHealth Group investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW), Cuisine Solutions (CUSI) and InnerScope Hearing Technologies (INND).

Company Calendar

• Last Earnings: 4/17/2025
• Record date for 6/24 Dividend: 6/16/2025
• Ex-Dividend for 6/24 Dividend: 6/16/2025
• Dividend Payable: 6/24/2025
• Today: 6/29/2025
• Next Earnings (Estimated): 7/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED - HMO
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:UNH
• CIK: 731766
• Web: www.unitedhealthgroup.com
• Phone: (952) 936-1300
• Fax: 952-936-1819
• Employees: 400,000
• Year Founded: 1977

Price Target and Rating

• Average Stock Price Target: $415.57
• High Stock Price Target: $700.00
• Low Stock Price Target: $270.00
• Potential Upside/Downside: +34.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 25 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $23.88
• Trailing P/E Ratio: 12.93
• Forward P/E Ratio: 10.46
• P/E Growth: 1.46
• Net Income: $14.41 billion
• Net Margins: 5.39%
• Pretax Margin: 6.87%
• Return on Equity: 26.29%
• Return on Assets: 8.67%

Debt

• Debt-to-Equity Ratio: 0.71
• Current Ratio: 0.85
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $400.28 billion
• Price / Sales: 0.70
• Cash Flow: $32.34 per share
• Price / Cash Flow: 9.55
• Book Value: $106.78 per share
• Price / Book: 2.89

Miscellaneous

• Outstanding Shares: 907,140,000
• Free Float: 904,600,000
• Market Cap: $280.17 billion
• Optionable: Optionable
• Beta: 0.45